| PERIOD ENDING | 31-Dec-06 | 31-Dec-05 | 31-Dec-04 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 332 | 813 | 161 | | Selling General and Administrative | 1,296 | 6,136 | 5,643 | | Non Recurring | 522 | 1,950 | 3,533 | | Others | 2,703 | 1,807 | 1,612 | | | | Total Operating Expenses | 4,853 | 10,706 | 10,948 | | | | Operating Income or Loss | (4,853) | (10,706) | (10,948) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (4,853) | (10,706) | (10,948) | | Interest Expense | 80 | 10 | 2 | | Income Before Tax | (4,933) | (10,715) | (10,951) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,933) | (10,715) | (10,951) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,933) | (10,715) | (10,951) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,933) | ($10,715) | ($10,951) |
|
0.20% Nasdaq 
Income Statement
